Latest Breaking News On - Pushkal garg - Page 1 : comparemela.com

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.

Rhode-island
United-states
Italy
Sweden
Spain
Germany
Tolga-tanguler
Raymond-james
Maury-raycroft
Pushkal-garg
Gary-nachman
Jeff-poulton

Is Alnylam's HELIOS-B Delay A Red Flag? (NASDAQ:ALNY)

Is Alnylam's HELIOS-B Delay A Red Flag? (NASDAQ:ALNY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Pushkal-garg
Pfizer
Huge-opportunity
Transthyretin-amyloidosis

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q4 2023 Earnings Call Transcript

Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.1, expectations were $-1.2.

United-states
Italy
Canada
Germany
Japan
Spain
Christine-lindenboom
Pushkal-garg
Kostas-biliouris
Ellie-merle
Akshay-vaishnaw
Jeff-poulton

Alnylam changes to heart drug trial spark doubts, sinking shares

BioPharma

Pushkal-garg
Akshay-vaishnaw
Yvonne-greenstreet
Bio-pharma
Alnylam-pharmaceuticals
Pfizer
Dive-brief
Bridgebio-pharma
Clinical-trials

Alnylam changes analysis plan for key Amvuttra heart trial, jolting investors

Alnylam changes analysis plan for key Amvuttra heart trial, jolting investors
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

William-blair
Pushkal-garg
Yvonne-greenstreet
Pfizer